Skip to main content
Skip to section navigation
Skip to footer
Home
Home
About Us
Programs
Anti-TNF
Synthetic CBD Analogs (SCAs)
a7nAChR Program
Pipeline
Leadership
Investors
Contact Us
Contact Us
Section 16 Filings
Investors
Investors
Overview
News & Events
Overview
Press Releases
IR Calendar
Email Alerts
Company Info
Overview
Management Team
Presentations
Contacts
FAQ
Financial Info
Overview
Financial Results
Income Statement
Balance Sheet
Cash Flow
Stock Data
Quote
Charts
Historical Data
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Overview
Board of Directors
Board Committees
Governance Documents
Filing Type:
View All
3
3/A
4
4/A
Year:
View All
2024
2023
2022
2021
2020
2019
2018
2017
2016
Date
Form
Description
PDF
XBRL
Pages
06/01/17
3
Initial statement of beneficial ownership of securities
1
rss_feed
Filing RSS
Previous Page
arrow_back
Page
1
…
…
Page
4
Page
5
Page
6
Page
7
Page
8
Page
9
Page
10
Page
11
Page
12
Page
13
Email Alerts
Contacts
RSS News Feed